Table E1.
Demographic/clinical features and serum sIgE levels of the study population, used explicitly in avidity assays (n = 60)
| Feature | PA (n = 36) | PS (n = 24) | P value∗ |
|---|---|---|---|
| Age (y) | 8.37 (2.06-16.27) | 6.05 (0.52-13.71) | .0155 |
| Sex: male | 24 (66.67) | 15 (62.5) | — |
| SPT to peanut (mm) | 10 (1-34) | 3 (0-9)∗ | <.0001 |
| tIgE (kUA/L) | 518 (19-3550) | 547 (28-6036) | .5845 |
| sIgE to peanut (kUA/L) | 31.95 (1.2-568) | 5.195 (0.99-20.9) | .0005 |
| sIgE to Ara h 1 (kUA/L) | 8.92 (0-199) | 0.16 (0-11.4) | .0099 |
| sIgE to Ara h 2 (kUA/L) | 12.3375 (0.05-278) | 0.07 (0-0.52) | <.0001 |
| sIgE to Ara h 3 (kUA/L) | 1.475 (0-89.6) | 0.07 (0.02-7.28) | .0115 |
| sIgE to Ara h 6 (kUA/L) | 10.17 (0-155) | 0.03 (0-0.49) | <.0001 |
| sIgE to Ara h 8 (kUA/L) | 0.215 (0-185) | 0.11 (0-88.6) | .7787 |
| sIgE to Ara h 9 (kUA/L) | 0.04 (0-8.71) | 0.13 (0-13.9) | .0354 |
Values are expressed as n (%) or median (range). P value refers to the comparison between PA and PS patients and was generated using Mann-Whitney t tests.
∗
SPT in PS individuals (n = 23).